# Armata Pharmaceuticals, Inc.: Form 8-K, filed May 19, 2025

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: 8-K
- Filed: 2025-05-19
- Accepted by EDGAR: May 19, 2025, 07:06 ET
- Period: 2025-05-19
- Accession: 0001104659-25-050219
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000110465925050219/tm2515395d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000110465925050219/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000110465925050219/tm2515395d1_8k.htm

Filed May 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-050219. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.